Core-shell upconversion nanoparticle - semiconductor heterostructures for photodynamic therapy

Core-shell nanoparticles (CSNPs) with diverse chemical compositions have been attracting greater attention in recent years. However, it has been a challenge to develop CSNPs with different crystal structures due to the lattice mismatch of the nanocrystals. Here we report a rational design of core-shell heterostructure consisting of NaYF4:Yb,Tm upconversion nanoparticle (UCN) as the core and ZnO semiconductor as the shell for potential application in photodynamic therapy (PDT). The core-shell architecture (confirmed by TEM and STEM) enables for improving the loading efficiency of photosensitizer (ZnO) as the semiconductor is directly coated on the UCN core. Importantly, UCN acts as a transducer to sensitize ZnO and trigger the generation of cytotoxic reactive oxygen species (ROS) to induce cancer cell death. We also present a firefly luciferase (FLuc) reporter gene based molecular biosensor (ARE-FLuc) to measure the antioxidant signaling response activated in cells during the release of ROS in response to the exposure of CSNPs under 980 nm NIR light. The breast cancer cells (MDA-MB-231 and 4T1) exposed to CSNPs showed significant release of ROS as measured by aminophenyl fluorescein (APF) and ARE-FLuc luciferase assays, and ~45% cancer cell death as measured by MTT assay, when illuminated with 980 nm NIR light.

Medienart:

E-Artikel

Erscheinungsjahr:

2015

Erschienen:

2015

Enthalten in:

Zur Gesamtaufnahme - volume:5

Enthalten in:

Scientific reports - 5(2015) vom: 05. Feb., Seite 8252

Sprache:

Englisch

Beteiligte Personen:

Dou, Qing Qing [VerfasserIn]
Rengaramchandran, Adith [VerfasserIn]
Selvan, Subramanian Tamil [VerfasserIn]
Paulmurugan, Ramasamy [VerfasserIn]
Zhang, Yong [VerfasserIn]

Links:

Volltext

Themen:

Journal Article
Reactive Oxygen Species
Research Support, Non-U.S. Gov't
SOI2LOH54Z
Solutions
Zinc Oxide

Anmerkungen:

Date Completed 25.11.2015

Date Revised 13.11.2018

published: Electronic

Citation Status MEDLINE

doi:

10.1038/srep08252

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM245958967